Viewing Study NCT04278092


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2025-12-24 @ 3:22 PM
Study NCT ID: NCT04278092
Status: COMPLETED
Last Update Posted: 2025-05-08
First Post: 2020-02-18
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module